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Objectives. We sought o determine whether internal mammary 
artery grafts adapt o an increase in myocardial flow demand and 
whether they restore maximal flow reserve. 
Background. Although mammary grafts are now considered the 
graft of choice for coronary artery bypass urgery, there is still 
controversy about whether they can provide adequate flow at 
periods of peak myocardial demand. 
Methods. Of 28 patients with a mammary graft anastomosed to 
the left anterior descending coronary artery, 15 were studied early 
(mean [-+SD] 8 -+ 2 days) and 13 late (19 +- 15 months) after 
operation by quantitative angiography and selective intravascular 
Doppler analysis at baseline, during pacing and after injection of 
papaverine and isosorbide dinitrate into the graft. Eleven patients 
with a normal eft anterior descending artery served as control 
subjects. 
Results. At baseline, mean graft diameter (2.39 _+ 0.41 vs. 2.42 --- 
0.45 mm) and bypass flow (38 -+ 22 vs. 30 -+ 12 ml/min) were 
similar in the early and late postoperative p riods. Significant and 
similar vasodilation was observed in mammary grafts after ad- 
ministration of papaverine (+6 + 5% vs. +9 -+ 6%) and nitrates 
(+14 -+ 7% vs. +16 -+ 9%) both early and late after bypass 
surgery. Graft diameter increased uring pacing late (+6 -+ 3%, 
p < 0.05) but not early after operation. Bypass flow increased 
similarly during pacing in both groups, but maximal f ow reserve 
induced by papaverine was significantly ower in mammary grafts 
studied early (2.70 -+ 0.62) than those studied late (3.66 + 0.81, 
p < 0.01) and in normal coronary arteries (4.05 + 0.96, p < 0.001). 
Conclusions. An increase in myocardial blood flow induced by 
pacing resulted in vasodilation of mammary grafts in the late but 
not in the early postoperative p riod. Significant vasodilation of 
mammary grafts after papaverine and isosorbide dinitrate admin- 
istration was observed both early and late after operation. How- 
ever, bypass flow reserve after papaverine injection was signifi- 
cantly lower in the early postoperative p riod but normalized over 
time. This finding seems unrelated to the conduit; rather, it 
appears to be related to the periphery and could be the result of 
injury to the microvasculature during operation. 
(JAm CoU Cardiol 1995;25:1120-8) 
Coronary artery bypass surgery is a widely used therapeutic 
measure for symptomatic coronary artery disease. The internal 
mammary artery is now considered the graft of choice because 
of its high long-term patency rate (1-3). Use of at least one 
mammary artery anastomosed to the left anterior descending 
coronary artery has resulted in a reduction in risk of late 
cardiac events and an improvement in survival (2-4). 
However, there is still a controversy over whether mam- 
mary grafts can provide adequate flow supply at periods of 
peak myocardial demand (5-8). Mammary grafts are narrower 
and longer than saphenous vein grafts and might have greater 
resistance to coronary blood flow. Several methods have been 
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used to evaluate the flow capacity of mammary grafts, includ- 
ing intraoperative graft flow measurements (9-14), implant- 
able Doppler miniprobes (15), dye-densitometric te hniques 
(16), digital substraction angiographic techniques (17) and 
myocardial scintigraphy (18-21), but the results remain con- 
troversial (22), mainly because of underestimation f bypass 
flow reserve by the technique used. In addition, clinical condi- 
tions suggesting inadequate perfusion by mammary grafts, 
mostly in the perioperative period, have been reported 
(6,23,24). 
The development of quantitative angiography (25,26) and 
intravascular Doppler velocity analysis (2%31) has enabled 
accurate, repeated measurements of bypass flow. The first 
studies were limited by the size of the Doppler catheter (3F), 
which could impair the flow in the conduit (27). More recently 
a Doppler-tipped 0.018-in. (0.037-cm) diameter guide wire has 
been validated for accurate measurement of intravascular flow 
velocity (28-31). 
In the present study we sought to determine whether 
mammary grafts can adapt o an increase in flow demand and 
thus restore the normal flow reserve capacity of bypassed 
vessels. Furthermore, we compared the adaptation of mam- 
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Table 1. Clinical Characteristics of Study Patients 
Mammary Artery Graft 
LAD Early Postop Late Postop 
(n = 11) (n = 15) (n 13) 
Demographic data* 
Age (yr) 59 +- 10 60 ± 10 59 + 10 
Gender (M/F) 5/6 15/0 8/5 
Postop delay 8 + 2 d 19 ~ 15 mo 
Risk factors 
Hypertension (%) 30 40 27 
Diabetes mellitus (%) 0 13 18 
History of smoking (%) 40 57 45 
Cholesterol level (mg/dl) 280 + 25 263 ± 55 259 _+ 43 
Hemoglobinemia (mg/dl) 13.8 ± 0.4 10.6 ± 0.6 14.8 + 1.7' 
Baseline heart rate (beats/min) 71 -+ 11 81 + 12 80 + 10 
Baseline blood pressure (ram Hg) 101 -+ 8 82 "2- 16 107 + 13' 
Angiographic data* 
% stenosis of LAD - -  77 ,+ 19 93 -+ 11 
Normal regional function 11/1l 12/15 10/13 
Extent of runoff (1-3) 3.0 + 0.0 2.4 ± 0.7 2.6 _+ 0.6 
Vessel diameter (ram) 2.92 + 0.54 2.39 ± 0.41 2.42 _+ 0.45 
IMA/LAD diameter - -  1.20 ± 0.12 1.34 ± 0.24 
Baseline flow data 
Average peak velocity (cm/s) 28 ,+ 7 26 ± 10 22 + 4 
Diastolic/systolic velocity ratio 2.03 ± 0.72 1.43 ± 0.67 0.70 + 0.20* 
Flow (ml/min) 57 -+ 22 38 --- 22 30 ,+ 12 
*p < 0.01 versus internal mammary, artery lIMA) graft at early postoperative (Early Postop) period. Data presented 
arc mean value _+ SD. F = female; LAD - left anterior descending coronary artery'; Late Postop = Late postoperative 
period: M = male. 
mary grafts in the early postoperative period with that of 
long-term grafts studied late after coronary artery bypass 
surgery. The grafts were investigated uring a moderate in- 
crease in blood flow induced by pacing and after papaverine 
administration, which is known to induce a maximal increase in 
blood flow (32-34). 
Methods  
Patients. Twenty-eight patients with an internal mammary 
artery anastomosed to the left anterior descending coronary 
artery were studied uring cardiac catheterization. Their clin- 
ical characteristics are shown in Table 1. The patients were 
investigated in the context of a postoperative angiographic 
follow-up study, and all were asymptomatic. Criteria for inclu- 
sion were an angiographically normal graft with good runoff 
and the absence of severe wall motion abnormalities in the 
revascularized areas. The extent of the revascularized area 
(runoff) was qualitatively graded from 1 (small runoff) to 3 
(large runoff), depending on the number of diagonal branches 
arising from the left anterior descending artery and the length 
of these arteries. Fifteen patients were studied in the early 
postoperative period, just before hospital discharge, and 13 
others in the late postoperative p riod, at least 11 months after 
operation. There was no difference in risk factors, regional 
function and quality of runoff between patients tudied early 
versus late after operation (Table l). Eleven patients with a 
normal eft anterior descending artery who were investigated 
for atypical chest pain and underwent the same protocol served 
as the control group. All patients gave informed consent to the 
study, which was approved by the ethics committee of our 
institution. All vasoactive drugs were discontinued 1 to 2 days 
before the study. 
Study protocol. Coronary angiography was performed by 
standard femoral approach. Selective injection of the native 
coronary arteries and grafts was performed by diagnostic 6F 
catheters. A projection for optimal visualization of the graft 
near the center of the 7-in. (17.8-cm) image-intensifier field 
was chosen, and all subsequent injections were performed 
according to standard quantitative angiography: calibration 
using the empty diagnostic atheter, unchanged single projec- 
tion throughout the study and nonionic contrast medium 
(iohexol, 350 mg of iodine/100 ml). All angiography was 
performed with manual injection. After injection of a single 
bolus of 5,000 IU of heparin, a 0.018-in. (0.037-cm) Doppler 
guide wire (Flowire, Cardiometrics) was advanced through a 
6F catheter into the initial portion of the graft and was 
adjusted until a good blood flow velocity signal was obtained. 
A 5F unipolar pacing wire was placed into the right atrium. 
Blood flow velocity, arterial blood pressure obtained through 
the coronary catheter and the electrocardiogram (ECG) were 
recorded throughout the study. 
The time course of the study protocol was as follows: 
Measurements of coronary blood flow velocity at rest, as well 
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as a baseline angiogram, were first obtained at least 3 min after 
the last contrast injection. Two minutes later, heart rate was 
increased by atrial pacing to 130 beats/rain. At the end of a 
2-rain period of pacing, blood flow velocity was recorded, and 
a second angiogram was obtained. Two minutes later, 12 mg of 
papaverine (2 mg/ml, 0.9% saline solution) was injected di- 
rectly into the graft, and the resultant increase in blood flow 
velocity was recorded. At maximal hyperemia, a third anglo- 
gram was obtained. Important but asymptomatic ST segment 
changes were commonly observed after papaverine adminis- 
tration, and one patient experienced nonsustained polymor- 
phic ventricular tachycardia (resembling torsades de pointe), 
as has been reported with papaverine (33,34). Three minutes 
after angiography with papaverine, when blood flow velocity 
had returned to baseline, 2 mg of isosorbide Dinitrate was 
injected irectly into the graft. The resultant increased in blood 
flow velocity was recorded, and the last angiogram was ob- 
tained 1 rain later. Heart rate and arterial pressure were 
measured immediately before each angiogram. 
Quantitative angiographic analysis. Quantitative analysis 
of grafts was performed with an automated coronary analysis 
program with edge contour detection that was implemented at 
a Cardiac Work Station (Philips, Eindhoven, The Netherlands) 
connected to a Digital Cardiac Imaging System (DCI, Philips) 
at our catheterization laboratory. The first well opacified 
end-diastolic frame detected by simultaneous ECG recording 
was selected for analysis. The lumen diameter of the same 
vessel segment, identified by anatomic reference points at the 
level of the blood velocity recording, was measured by auto- 
mated contour detection algorithms. Absolute dimensions 
were calculated by reference to the known size of the shaft of 
the empty catheter, measured 2 to 3 cm from the tip positioned 
within the ostium of the graft. The cross-sectional rea of the 
graft was computed, assuming a circular cross section. The 
ratio between the graft diameter measured 2 to 3 cm proximal 
to the anastomosis to the left anterior descending coronary 
artery and the diameter of the left anterior descending artery 
at the level of the mammary anastomosis was also calculated in 
grafts early and late after bypass. Measurements of vessel 
dimensions were previously evaluated for precision and short- 
term variability in our laboratory in 22 patients by means of 
two angiograms obtained 3min apart. The mean difference in 
lumen diameter measured from the two angiograms was 
0.06 mm (2%), and the measurement variability (standard 
deviation of the mean difference) was also 0.06 mm. 
Flow velocity measurements. All bypass flow velocity mea- 
surements with the Doppler guide wire (Flowire, Cardiomet- 
rics) were performed as previously described (31,35). In brief, 
the 0.018-in. (0.037-cm) guide wire has a 12-MHz piezoelectric 
ultrasound transducer atits distal tip and permits recording of 
flow velocity from the frequency shift between the transmitted 
and returning signals. Time-averaged and instantaneous peak 
velocity values are processed by a computer using fast Fourier 
transformation techniques that display a gray-scale depiction 
of all velocities recorded in the sample volume at one point in 
time. Bypass blood flow was estimated as previously validated 
by Doucette t al. (31) as the product of average velocity and 
cross-sectional rea. Average peak velocity was calculated 
on-line by the system, and average velocity was derived as the 
average peak velocity/2, assuming a time-averaged parabolic 
velocity profile across the vessel (31). The diastolic/systolic 
peak velocity ratio was computed from the digitized spectral 
velocities from the average of three cardiac ycles. In the 11 
control patients, we assessed the stability and reproductibility 
of velocity and flow measurements for20 min during a similar 
protocol. Flow measurement variability between two measure- 
ments of blood flow at 20-rain intervals was 4%, mainly as a 
result of variability in measurements of vessel dimensions, 
because velocity remained almost unchanged. Maximal bypass 
flow reserve was calculated as the ratio of peak blood flow after 
papaverine administration to blood flow at rest. 
Statistical analysis. Results are expressed as mean value 
_+ SD in text and Table 1; in the figures they are expressed as 
mean value _ SEM. Vessel diameters expressed in absolute 
values were compared for changes during pacing after admin- 
istration of isosorbide dinitrate and papaverine using one-way 
analysis of variance for repeated measurements. Changes in 
grafts in the early and in late postoperative p riods, as well as 
in normal control coronary arteries, were compared using a 
nonparametric Mann-Whitney-Wilcoxon test. 
Resul ts  
Baseline characteristics. Mean heart rate was similar 
(81 +_ 12 vs. 80 ~ 10 beats/rain), but mean blood pressure was 
lower by 25 mm Hg, early than late after bypass urgery (p < 
0.01) (Table 1). Hemoglobinemia w s also slightly lower in the 
early postoperative p riod (11 _+ 1 vs. 15 _+ 2 g/dl, p < 0.01). 
No significant change in mean heart rate or mean arterial 
blood pressure was observed after injection of nitrates or 
papaverine. Both groups of patients achieved asimilar increase 
in mean heart rate during pacing, with no significant change in 
mean blood pressure. No difference in regional function or 
quality of runoff was observed between the two groups of 
patients. 
Graft dimensions and average peak velocity were similar 
between the early and late postoperative periods. Diastolic/ 
systolic velocity ratio was higher early after operation than 
later (1.43 _+ 0.67 vs. 0.70 +_ 0.20, p < 0.001) (Fig. 1). Bypass 
flow was slightly but not significantly higher early after bypass 
surgery than later (38 _+ 22 vs. 30 _+ 12 ml/min) (Fig. 2). 
Normal eft anterior descending coronary arteries were slightly 
larger (2.92 + 0.54 mm) than mammary grafts in the early 
(2.39 _+ 0.41 ram) and late (2.42 +_ 0.45 ram) postoperative 
periods, whereas average peak velocity was similar to that in 
mammary grafts. Accordingly, baseline flow, measured proxi- 
mally in left anterior descending coronary arteries, was also 
higher (57 _+ 22 ml/min) than that in mammary arteries, which 
were grafted more distally. 
Quantitative angiographic data. Significant vasodilation 
during pacing was observed in mammary grafts (+6 _ 3%, p < 
0.001 vs. baseline) (Fig. 3 and 4) in the late postoperative 
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Figure 2. Comparison between baseline bypass flow in internal mam- 
mary artery (IMA) grafts in the early (E) and late (L) postoperative 
periods. Baseline flow was similar in the two groups. Early after bypass 
surgery, one patient (open circle) had unexplained very high baseline 
flow. His bypass flow reserve was also severely reduced. Except for this 
patient, no relation was observed between bypass flow and flow 
reserve. 
Figure 1. Typical recording of blood flow velocity in the proximal 
segment of mammary artery grafts in the early (top) and late (bottom) 
postoperative p riods. Early after operation, flow was predominantly 
diastolic (D) but become predominantly s stolic (S) late after opera- 
tion. 
period only. In normal coronary arteries, vasodilation was of 
borderline significance due to three patients with paradoxal 
vasoconstriction during pacing (Fig. 4). After papaverine, 
mammary graft diameters increased by 0.14 _+ 0.10 mm early 
after surgery (+6 Z 5%, p < 0.001 vs. baseline) and by 0.21 _+ 
0.11 mm late after surgery (+9 _+ 6%, p < 0.001 vs. baseline; 
p = NS for early vs. late vasodilation after papaverine) (Fig. 3). 
With isosorbide dinitrate, there was a similar increase in 
mammary graft diameters of 0.33 _+ 0.14 mm (+14 _+ 7%, p < 
0.001 vs. baseline) and 0.36 _+ 0.14 mm (+16 _+ 9%, p < 0.001 
vs. baseline) early and late after bypass surgery, respectively 
(Fig. 3). Vasodilation with papaverine and nitrates was slightly 
but not significantly higher in normal coronary arteries than in 
mammary grafts (+17 _+ 15% and +25 _+ 20%, respectively, 
both p < 0.001 vs. baseline). 
Bypass flow data. After dye injection, flow velocity in- 
creased significantly less in mammary grafts in the early 
(+65 + 25%) versus late (+105 _+ 31%, p < 0.001) postop- 
erative period. During pacing, flow velocity increased similarly 
early and late after bypass urgery (+24 _+ 14% vs. +21 + 8%, 
p = NS) (Fig. 5). Because vessel dimensions increased signif- 
icantly in the late postoperative period only (Fig. 3), the 
increase in flow in mammary grafts during pacing was slightly 
higher late than early after operation (+36 + 13% vs. +29 +_ 
16%, p = NS) (Fig. 5). However, the increase in flow during 
pacing was lower in mammary grafts early after operation than 
in normal coronary arteries (+44 _+ 19%, p < 0.05) but was 
similar in mammary grafts late after operation and in left 
anterior descending coronary arteries. Flow velocity increased 
markedly but briefly with isosorbide dinitrate. In mammary 
grafts, maximal increase in velocity was also lower in the early 
than in late postoperative p riod (+182 + 54% vs. 146 _+ 33%, 
respectively, p < 0.01). However, at 1 min, velocity had nearly 
returned to baseline, and, essentially because of the net 
vasodilation observed (Fig. 3), bypass flow increased in mam- 
mary grafts by 38% and 51% early and late after operation, 
respectively (p < 0.01 vs. baseline; p = NS, early vs. late 
postoperative period). With papaverine, velocity in mammary 
grafts increased by 138 _+ 48% in the early postoperative 
period, less than in the late postoperative period (+208 + 
49%, p < 0.01 vs. early after operation) and in normal 
coronary arteries (+196 _+ 31%, p < 0.025 vs. early after 
operation and p = NS vs. late after operation) (Fig. 6). 
Accordingly, maximal bypass flow reserve was also very signif- 
icantly decreased in mammary grafts at early versus late study 
(2.70 _+ 0.62 vs. 3.66 _+ 0.81, p < 0.01) and versus normal 
coronary arteries (4.05 _+ 0.96, p < 0.001). 
1124 GURNI~ ET AL. JACC Vol. 25, No. 5 
FUNCTIONAL EVALUATION OF MAMMARY GRAFTS April 1995:1120-8 
2O 
lO 
PACING 
EARLY IMA 
PAPAV ISDN 
LATE IMA 
PACING PAPAV 
- I -  
777;~| 
ISDN 
Figure 3. Comparison ofchange in diameter (DEL- 
TA DIAMETER) observed with pacing and admin- 
istration of papaverine (PAPAV) and isosorbide di- 
nitrate (ISDN) in internal mammary grafts (IMA) 
early and late after operation. *p < 0.01 versus 
baseline. 
Discussion 
Our data show that coronary artery bypass grafting with the 
internal mammary artery restores nearly normal flow reserve 
in the late but not early postoperative period (Fig. 6). Quan- 
titative angiography, combined with intravascular Doppler 
imaging, allows assessment of whether grafts adapt to in- 
creased flow demand. During pacing, we observed that long- 
term, not short-term, mammary grafts also have the capacity to 
adapt heir size dynamically to flow demand (Fig. 3 and 4). 
Restoration of flow reserve by mammary grafts. Although 
mammary grafts are now used widely and increasingly, the 
problem of restoring normal hemodynamic performance in 
coronary artery bypass grafts is still unresolved (5-8). In the 
perioperative period, clinical conditions uggesting inadequate 
perfusion by mammary grafts have been reported (6,7,24,25) 
and are attributed to a disproportionate r lation between 
flow and myocardial demand. Furthermore, Tedoriya et al. (8) 
used an animal model to show that mammary grafts could be 
less physiologically advantageous than grafts originating from 
the ascending aorta in their ability to supply blood to the 
predominantly diastolic coronary circulation. Diastolic flow 
was significantly lower in a pedicled mammary graft than in a 
graft emerging from the ascending aorta. Our results are in 
accordance with their finding because the diastolic/systolic 
velocity ratio measured proximally in our long-term mammary 
grafts was 0.70 + 0.20 (i.e., predominantly s stolic flow). Bach 
et al. (35) used long-term mammary grafts to show a similar, 
predominantly systolic pattern in the proximal part of the 
mammary graft but not distally, where they found a predomi- 
nantly diastolic pattern. Surprisingly, in short-term ammary 
grafts, we found predominantly diastolic flow measured in the 
proximal part of the graft. The transition from a predominantly 
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Figure 4. Individual data for increase indiameter (DELTA 
DIAM) of internal mammary artery (IMA) grafts with 
pacing early (E) and late (L) after bypass urgery and in 
normal left anterior descending coronary arteries (LAD). 
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Figure 5. Comparison of change (DELTA) in 
velocity and flow (as percent of baseline velocity or 
flow) during pacing in internal mammary artery 
(IMA) grafts early and late after bypass surgery 
and in normal left anterior descending coronary 
arteries (LAD). 
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diastolic pattern in short-term grafts to a predominantly s s- 
tolic pattern in long-term grafts might be related to differences 
in the intrinsic properties of the mammary artery wall (36) and 
in the elasticity of the walls of short- and long-term mammary 
grafts. However, to our knowledge, no experimental data are 
available to support his hypothesis. 
Several perioperative studies (9-16) have shown that blood 
flow in newly anastomosed mammary grafts is lower than in 
vein grafts at rest or after ischemic reactive and pharmacolog- 
ically induced coronary hyperemia. In contrast, other studies 
(1%21) performed later after bypass urgery have suggested 
that these alterations in blood flow are transient. They re- 
ported equal flow supply at rest and after stimulation in 
mammary grafts and in venous grafts or normal coronary 
arteries. However, studies of flow reserve late after mammary 
graft surgery have been hampered by methodologic problems, 
such as underestimation of bypass flow reserve, due either to 
the technique used to measure bypass flow or to the stimulus 
used to test flow reserve (22). Nevertheless, in a study by 
Kawasuji et al. (6) using radionuclide ventriculography moni- 
toring during exercise, a higher proportion of patients had a 
decrease in regional eft ventricular ejection fraction during 
exercise, suggesting inadequate flow for maximal demand in 
patients with a mammary versus a venous graft anastomosed to 
the left anterior descending coronary artery. However, these 
patients were studied 1 month after bypass urgery (in contrast 
to our patients who were studied at least 11 months after 
revascularization), and no data are available on the quality of 
the revascularization a d runoff of the grafts. Dion et al. (4) 
reported a 7.4% incidence of abnormal findings on maximal 
stress thallium scintigraphy in 400 patients with bilateral 
mammary grafts and late angiographic controls, but many of 
Figure 6. Comparison of change (DELTA) in 
velocity (as percent of baseline velocity) and 
maximal bypass flow reserve after papaverine 
injection (maximal flow after papaverine/baseline 
flow ratio). Abbreviations a in Figure 5. 
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the patients with abnormal stress thallium scintigraphic results 
either had an occluded graft or progression of native coronary 
artery disease. 
In our study, flow was measured by quantitative angiogra- 
phy combined with intravascular Doppler imaging (31). This 
technique is accurate for measuring blood flow even over the 
range that can occur in normal coronary vessels and thus 
should not underestimate the increase in flow in our protocol. 
Maximal flow reserve was studied by selective injection of 
papaverine directly into the graft at a dosage sufficient o 
induce maximal vasodilation (32,33). Our results show that 
flow reserve was reduced in mammary grafts in the early versus 
late postoperative period and in normal coronary arteries (Fig. 
6). Flow reserve, the ratio of maximal hyperemic flow to rest 
flow, depends on several factors (22,37) that must be consid- 
ered in any attempt to clarify the mechanisms involved in the 
reduced flow reserve observed early after operation. 
First, coronary blood flow at rest should be a true baseline 
flow and should be comparable among the different patients. 
In our patients, baseline flow was similar between the early and 
late postoperative periods (Fig. 2). Despite the finding that 
patients tudied early were slightly anemic, which could in- 
crease blood flow (38), their blood pressure was lower than 
that in patients tudied later, which could counteract this 
effect. Heart rate, another important determinant of myocar- 
dial blood flow, and one that can interfere with the reproduc- 
ibility and variability of coronary flow reserve measurements 
(37), was not different between early and late mammary grafts. 
Second, the characteristics ofthe bypass conduit have to be 
evaluated. However, in our patients there was no difference 
between short- and long-term grafts with regard to graft size, 
graft/coronary size ratio and vasodilatory response to papav- 
erine (Fig. 3). Thus, it is unlikely that graft dimensions played 
a role in the difference in bypass flow reserve observed. 
Third, the epicardial coronary arteries and myocardium 
revascularized by the graft must be comparable. Wilson et al. 
(22) demonstrated in saphenous venous grafts that restoration 
of normal maximal f ow reserve only occurred in grafts perfus- 
ing a nonstenotic coronary vessel and normal myocardium. In 
their study, moderate diffuse coronary atherosclerosis did not 
significantly impair flow reserve. In the normal coronary 
circulation, blood flow is regulated more by the arteriolar bed, 
and epicardial coronary vessels provide little resistance to flow. 
In our patients, epicardial coronary arteries were free of 
significant stenosis distal to the anastomosis at both early and 
late study. All patients had severe narrowing or complete 
obstruction of the grafted left anterior descending coronary 
artery proximal to the anastomosis, thereby minimizing the risk 
of flow competition. In the early postoperative period, it is also 
difficult o exclude some degree of stunning still present after 
bypass surgery. The finding that bypass flow during pacing 
increased less in mammary grafts early after operation than in 
normal coronary arteries could favor this hypothesis of stun- 
ning, at least in some patients. However, there was no signif- 
icant difference in regional function between grafts early and 
after operation. Thus, this cannot account for the profound 
difference in maximal flow reserve observed between mam- 
mary grafts early and late after bypass. 
Fourth, many abnormalities of the microvasculature (30,39) 
may diminish maximal flow capacity independently of the 
hemodynamic performance of the bypass conduit and epicar- 
dial coronary artery (40-46) (e.g., previous myocardial infarc- 
tion (40), ventricular hypertrophy (41,42) or prolonged hyper- 
tension (43). Hypertension and previous myocardial infarction 
were equally distributed between our two groups of patients, 
and no ventricular hypertrophy was present. The reduced flow 
reserve observed uring revascularization could be a direct 
result of the effect of cardioplegia on the microvasculature, 
insufficient myocardial protection during cardiopulmonary by-
pass (47), embolization of thrombi or humoral agents elabo- 
rated from embolized thrombi, as has previously been shown in 
unstable angina (48,49), and possibly abnormal vasodilation of 
microvessels already at rest. In our study, baseline flow, graft 
conduit dimensions, epicardial coronary arteries and myocar- 
dium were apparently similar between the early and late 
postoperative periods. Our results therefore favor a reduced 
maximal flow reserve early after operation due to peripheral 
factors probably related to an impairment of the microcircu- 
lation rather than the capacity of the conduit itself. 
Flow.induced vasodilation during pacing. Another impor- 
tant finding of our study is that mammary grafts can increase 
their diameter during pacing in the late postoperative p riod, 
in accordance with similar data obtained by Hanet et al. (50), 
By contrast, in the early postoperative period, mammary grafts 
do not show the ability to dynamically adapt their cross- 
sectional area to an abrupt increase in blood flow demand. 
Vasodilation during pacing allows the graft o increase its flow 
at lower velocities (Fig. 5). This could minimize the increase in 
shear stress and turbulent flow that promotes endothelial 
injury and atherosclerosis progression. Animal studies (51-53) 
have shown that increasing blood flow through normal arteries 
induced vasodilation mediated by the release of endothelium- 
deriving relaxing factor. This flow-induced vasodilation has 
been shown in different models in humans (50,54), including 
the coronary arteries of heart ransplant recipients (55) and in 
free epigastric artery bypass grafts (56). The absence of 
innervation of the latter conduits favors local regulation, 
probably related by the endothelium. Although our data do not 
provide direct evidence that the release of relaxing substance 
by the endothelium is responsible for the vasodilation observed 
during pacing, this response is most likely the angiographic 
manifestation f flow-induced endothelium-dependent vasodi- 
lation, confirming a preserved endothelium function in long- 
term mammary grafts, as suggested by other studies (5%59). 
The lack of significant vasodilation during pacing in mammary 
grafts in the early postoperative period despite normal vaso- 
dilation with nitrates (not endothelium-dependent vasodila- 
tion) could represent endothelial dysfunction (54) that may 
have been temporarily caused by the harvesting of the conduit 
or by the mechanisms underlying the early adaptation of the 
conduit o its new function. Recovery of endothelial function 
could be an important factor contributing to the function and 
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patency of mammary grafts, to their protection against prolif- 
eration of atherosclerotic changes and to their ability to adapt 
dynamically to the requirements of the coronary circulation 
(60-62). 
The lack of significant vasodilation i  the coronary arteries 
of our control group during pacing shows that signs of abnor- 
mal endothelium function can be found even in angiographi- 
cally normal coronary arteries (Fig. 4). Our control group 
comprised patients with high risk factors for atherosclerosis 
and with atypical chest pain who were referred for cardiac 
catheterization. Several studies (63,64) using quantitative an- 
giography and acetylcholine infusion or cold pressor testing 
have reported a significant relation between risk factors, 
particularly cholesterol levels, and endothelium dysfunction. 
Despite similar increased risk factors, and in contrast o 
coronary arteries, long-term mammary grafts maintain ormal 
endothelial function, as observed by Werner et al. (57) with 
acetylcholine. This could represent an important factor for the 
protection of the graft against atherosclerosis. 
Study limitations. The limitations of quantitative angiog- 
raphy and intraeoronary Doppler flow velocity measurements 
have been previously described (25,26,31,37). Use of the 6F 
catheter could result in some degree of obstruction of flow in 
the internal mammary artery. However, the same techniques 
were used in both short- and long-term grafts, allowing com- 
parison of flow reserve between the two groups. Furthermore, 
flow reserve in long-term grafts was normal compared with 
that in normal coronary arteries with a catheter placed in the 
left main coronary ostium, another finding in support of the 
hypothesis of no or minimal obstruction. Other limitations of 
our study include the relatively small number of patients 
studied and the fact that the patients studied late after 
operation are not the same as those studied early. Neverthe- 
less, flow reserve was markedly reduced early after operation 
compared with that in normal coronary arteries, and, by 
contrast, flow reserve in long-term grafts was found to be in the 
range of normal values. Another limitation is the existence of 
native anterograde flow in some patients, making it dflficult o 
determine whether the increase in flow was through the graft 
or through the native coronary artery. However, all grafts were 
anastomosed to severely narrowed coronary arteries, half of 
which were totally occluded. 
Conclusions and clinical implications. Quantitative an- 
giography combined with intravascular Doppler velocity anal- 
ysis appears to be a reliable technique for studying the 
hemodynamic performance of bypass conduits. From a func- 
tional point of view, our study confirms the excellent results 
with mammary artery grafts in coronary bypass urgery. These 
grafts are able to adapt their dimensions to flow demand, 
probably through a preserved endothelial function, at least in 
the late postoperative period. This enables them to adapt o 
blood flow requirements. The favorable vasomotor properties 
of mammary grafts are probably an important contributing 
factor to the excellent long-term clinical functional results 
observed in coronary artery bypass surgery. Furthermore, 
long-term mammary grafts can restore flow reserve to near 
normal evels. The reduced flow reserve observed in the early 
postoperative p riod seems to be related more to peripheral 
factors, such as an impairment of the microcirculation early 
after cardiopulmonary bypass than to the conduit itself. Clin- 
ically, the implantation of mammary grafts of adequate size 
(i.e., correct match of graft to coronary artery size) can be 
recommended, even in coronary arteries upplying a large 
territory, without unfavorable consequences. 
We thank the staff of the cardiac atheterization laboratory for their continued 
support during this study and Laurence Collin for typing the manuscript. 
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